Vasodilators in Chronic Heart Failure
Editat de H. Just Contribuţii de F. Burkart Editat de W. -D Bussmannen Limba Engleză Paperback – 6 dec 2011
Preț: 701.10 lei
Preț vechi: 737.99 lei
-5% Nou
Puncte Express: 1052
Preț estimativ în valută:
134.18€ • 139.37$ • 111.45£
134.18€ • 139.37$ • 111.45£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642686078
ISBN-10: 3642686079
Pagini: 256
Ilustrații: XVI, 236 p.
Dimensiuni: 170 x 244 x 13 mm
Greutate: 0.41 kg
Ediția:Softcover reprint of the original 1st ed. 1983
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642686079
Pagini: 256
Ilustrații: XVI, 236 p.
Dimensiuni: 170 x 244 x 13 mm
Greutate: 0.41 kg
Ediția:Softcover reprint of the original 1st ed. 1983
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
V-ar putea interesa
-
Meyler's Side Effects of Drugs Used in AnesthesiaJeffrey K. Aronson-5%Preț: 323.81 lei340.85 lei -
The ECG Criteria Book 2eJames H. O'Keefe-5%Preț: 205.09 lei215.88 lei -
-20%Preț: 716.14 lei892.51 lei -
Hypertension, Heredity and StrokeCristina Moratinos-27%Preț: 960.99 lei1316.42 lei -
Ventricular Fibrillation & Acute Coronary SyndromeJoyce E. Mandell-27%Preț: 1203.43 lei1649.48 lei -
Introduction to Translational Cardiovascular ResearchDennis V. Cokkinos-5%Preț: 1107.17 lei1165.45 lei -
Clinico-Pathological Atlas of Cardiovascular DiseasesJoaquín S. Lucena-5%Preț: 1119.64 lei1178.56 lei -
Pathophysiology and Pharmacotherapy of Cardiovascular DiseaseGowraganahalli Jagadeesh-5%Preț: 1460.25 lei1537.11 lei -
Thrombolysis in Pulmonary EmbolismCarlos Jerjes-Sánchez-5%Preț: 714.16 lei751.75 lei -
-5%Preț: 639.44 lei673.09 lei -
Sudden DeathH.E. Kulbertus-5%Preț: 371.34 lei390.88 lei
Public țintă
ResearchCuprins
I. Physiology.- Vasoconstrictor Mechanisms and the Effects of Nitrates.- Functional and Metabolic Consequences of Chronic Alterations in Preload and Afterload in the Hypertrophied and Dilated Heart.- The Sympathetic Nervous System in Chronic Heart Failure and Its Response to Vasodilator Therapy.- Regulation of Renal Hemodynamics in Congestive Heart Failure.- The Renin-Angiotensin-Aldosterone System in Congestive Heart Failure.- Endogenous Catecholamines Under Chronic Vasodilator Treatment.- Effects of Hydralazine and Isosorbide Dinitrate on Vasoconstrictor Mechanisms in Patients with Heart Failure.- II. Pharmacology.- Cellular Mechanism of Action of Directly Acting Vasodilator Drugs.- Pharmacokinetics of Nitrates.- Isosorbide Dinitrate: Pharmacokinetics After Intravenous Administration.- Prazosin and ?-Blocking Agents.- III. Clinical Experience.- Promises and Disappointments of Vasodilator Treatment of Chronic Heart Failure.- Nitrates in Chronic Heart Failure.- The Long-Term Effects of Dihydralazine and Hydralazine on Intractable Cardiac Failure.- The Use for Hydralazine in Chronic Cardiac Failure: Results and Unanswered Questions.- Prazosin Therapy in Severe Chronic Congestive Heart Failure.- Early Experience with Captopril in Congestive Heart Failure.- Acute Effect of Nifedipine on Left Ventricular Performance at Rest and During Exercise in Patients with Left Ventricular Dysfunction.- Treatment of Congestive Heart Failure with Dipyridamole.- Therapeutic Agents with Combined Inotropic and Vasodilating Properties.- Hemodynamic Effects of Combined Inotropic and Vasodilator Drugs in Severe Congestive Heart Failure: Hydralazine and Prenalterol.- AR-L 115 BS, a Substance with Inotropic and Vasodilating Effects.- Efficacy of AR-L 115 BS on Hemodynamics, Contractility, andMyocardial Oxygen Consumption in Man.- Treatment of Cardiac Failure with AR-L 115 BS.- IV. Conception and Planning of Future Studies.- Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure?.- Vasodilators in Chronic Heart Failure: Problems of Design and Analysis of Controlled Clinical Trials.